Scientific investigations

Size: px
Start display at page:

Download "Scientific investigations"

Transcription

1 Scientific investigations The Tongue-Retaining Device: Efficacy and Side Effects in Obstructive Sleep Apnea Syndrome Diane S. Lazard, M.D. 1 ; Marc Blumen, M.D. 2 ; Pierre Lévy, M.D. 3,4,5 ; Pierre Chauvin, M.D. 4,5 ; Dorothée Fragny, M.D. 2 ; Isabelle Buchet, M.D. 6 ; Frédéric Chabolle, M.D. 2 1 Assistance Publique-Hôpitaux de Paris, Hôpital Beaujon, Service d ORL et de Chirurgie Cervico-Faciale, Clichy, France; 2 Hôpital Foch, Service d ORL et de Chirurgie Cervico-Faciale, Suresnes, France; 3 Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Département de Santé Publique, Paris, France; 4 INSERM, U707, Paris, France; 5 Université Paris 6-Pierre et Marie Curie, UMR-S 707, Paris, France; 6 Hôpital Foch, Service de Stomatologie, Suresnes, France Study Objectives: The tongue-retaining device is a customized monobloc oral appliance used in the treatment of obstructive sleep apnea syndrome (OSAS). This study evaluated tongue-retaining device efficacy and its tolerance by patients with OSAS. Methods: The charts of 84 apneic patients were retrospectively analyzed, and patients were contacted by telephone to answer an oral questionnaire. The median follow-up time was 5 years. Results: Based on the apnea-hypopnea index, a complete or partial response was obtained in 71% of the cases. The mean apneahypopnea index decreased significantly from 38 to 14 (p < 0.001) with the tongue-retaining device. The subjective intensity of snoring decreased by 68% (p < ) and the Epworth Sleepiness Scale score decreased from 9 to 6 (p < 0.05). An age of more than 60 years associated with a mandibular protrusion distance inferior or equal to 7 mm was predictive of a nonresponse (odds ratio [OR]: 7.25; 95% confidence interval [CI]: ; p < 0.02). The compliance rate, as determined by answers to the questionnaire, was 52% after 5 years of follow-up. Nasal obstruction was a negative predictor of good compliance (OR: 6.94; 95% CI: ; p < 0.005), whereas patients with Class I occlusion were more compliant than patients with Class II or III occlusions (OR: 3.83; 95% CI: ; p < 0.05). Conclusions: Tongue-retaining device performance tended to be similar to that of the mandibular advancement device. Thus, teams trained in tongue-retaining device fabrication and fitting may propose it as an alternative to continuous positive airway pressure, taking nasal obstruction into consideration as a contraindication. Keywords: Oral appliance, apnea-hypopnea index, Epworth Sleepiness Scale, side effects, continuous positive airway pressure Citation: Lazard DS; Blumen M; Lévy P; Chauvin P; Fragny D; Buchet I; Chabolle F. The tongue-retaining device: efficacy and side effects in obstructive sleep apnea syndrome. J Clin Sleep Med 2009;5(5): The treatment of obstructive sleep apnea syndrome (OSAS) is based on either continuous positive airway pressure (CPAP), oral appliances or surgery. 1 CPAP is initially proposed in cases of severe or moderate OSAS with a high degree of somnolence. Oral appliances are an alternative to continuous positive airway pressure (CPAP) or to an operation in case of treatment failure or refusal. They are also proposed in cases of moderate OSAS without somnolence or mild OSAS. 1 Various models of oral appliances have been developed. The most widely used is the mandibular advancement device (MAD). 2 Among other models, the tongue-retaining device (TRD), a monobloc oral appliance that associates moderate mandibular protrusion with the maintenance of the tongue in an anterior position, has been infrequently used. Submitted for publication March, 2009 Submitted in final revised form July, 2009 Accepted for publication July, 2009 Address correspondence to: Dr. Diane Lazard, M.D., Hôpital Beaujon, Service d ORL et de Chirurgie Cervico-Faciale, 100 Boulevard du Général Leclerc, F Clichy Cedex, France; Tel: ; Fax: ; diane.lazard@bjn.aphp.fr Journal of Clinical Sleep Medicine, Vol.5, No. 5, Although the efficacy of TRD in snoring, sleep apnea, and daytime sleepiness has been shown in small populations, 3-8 its tolerance has appeared to be lower 7 than that of MAD 9 in some studies. This might be the reason why it is so seldom prescribed. 2 The aim of this study was therefore to evaluate TRD efficacy and side effects in a population of 84 patients with OSAS. Patients METHODS From June 1997 to July 2006, 107 patients with OSAS were fitted with a TRD in our center. TRD was proposed in 36 cases as an initial treatment (25 cases of moderate OSAS, 11 cases of mild OSAS), and in 71 cases after CPAP intolerance (severe OSAS). Twenty-three patients were not included in this retrospective study because their charts were too incomplete to be studied (initial polysomnography results and detailed clinical evaluation were missing). The charts of the remaining 84 patients were retrospectively analyzed.

2 DS Lazard, M Blumen, P Lévy et al Pretreatment Evaluation Clinical Evaluation All snoring patients underwent a detailed otorhinolaryngologic examination by 2 senior practitioners highly specialized in OSAS and trained to consult jointly. The clinical examination followed a standardized scheme, which consisted of noting physical characteristics (ie, age, size, and weight) and medical history (in particular, the presence of a nasal obstruction, anatomic or secondary to allergic rhinitis). The Epworth Sleepiness Scale (ESS) was used to evaluate daytime sleepiness (an ESS score 8 was considered pathologic, and patients with an ESS score 11 as highly symptomatic). 10 The sizes of the mobile tongue, tongue base, tonsils, and uvula were graded from 1 to 3 (small, medium, big) or 0 if the patient previously had surgery on one of these structures. The soft palate was classified as thin or plethoric. The relative position of the teeth and the relationship between the upper and lower jaw was evaluated (Class I: normal; Class II: retrognathic; Class III: prognathic). The level of snoring was evaluated by the bedpartner using a visual analog scale from 0 to 10 (0 = no snoring, 10 = snoring loud enough to be heard from another room). Po ly s o m n o g r a p h y Patients underwent an initial polysomnogram (pre-trd) consisting, at a minimum, of recording ventilatory parameters (ie, nasal flow through a nasal cannula, oximetry, and thoracic and abdominal movements) and quantifying sleep time, as evaluated by a questionnaire and by the stability and consistency of recorded signals (Level 3 polysomnography, according to the classification of the American Sleep Disorders Association 11 ) in all patients. In addition, sleep parameters (ie sleep stages, arousal index and microarousal index, and sleep latency) were recorded in some patients (n = 46, Level 2 polysomnography). Because sleep parameters were not available for all patients, only ventilatory parameters and sleep time were taken into account for the purposes of this study. In patients with supine apneas, learning to avoid the supine position 12 was systematically proposed as a first-line treatment in our center. Oral appliances were only indicated in patients who failed this rehabilitation. The subpopulation used for this study is therefore biased, and the results cannot be extrapolated to determine TRD efficacy in patients with supine apneas. The severity of the disease was classified according to the apnea-hypopnea index (AHI) as follows: severe OSAS, AHI of 30 or greater; moderate OSAS, AHI of at least 15 but less than 30; mild OSAS, an AHI of at least 10 but less than The TRD The TRD (Figure 1) was first described in It consists of a mouthpiece that covers the entire upper and lower dental arches, with a defined mandibular protrusion. It pulls the tongue slightly forward due to the negative pressure created by the displacement of air from the lingual compartment of the device. The TRD is custom made from casts of the tongue and teeth using a soft copolymer (Truplast, Orthoplus, Igny, France). The Figure 1 The tongue-retaining device. Tongue protraction is achieved due to the design of the device, which results in a slight negative pressure in the lingual compartment of the device, following the displacement of air once the tongue is placed in this compartment. initial mandibular protrusion is 50% to 75% of maximal protrusion. 13,14 This protrusion distance is reduced if the patient complains of pain and is increased if snoring remains unchanged after a 3-week trial. Lateral holes facilitate mouth breathing. All patients underwent a systematic dental examination by a stomatologist. Severe periodontal diseases were considered to be criteria for exclusion. For a good fit, we preferred that patients have a minimum of 6 teeth each on the superior and inferior dental arches. Nevertheless, the TRD is the only appliance suitable in case of edentulism and can be used in this case. To summarize, a TRD was proposed according to the AHI recorded during the initial polysomnogram in cases of daytime somnolence or after a CPAP failure. Oral Appliance Evaluation Polysomnography With TRD An outcome polysomnogram (post-trd polysomnography) after a minimum of one month of TRD use (from 1 to 91 months, median = 4) was systematically prescribed. Patients were required to wear the TRD during the test to evaluate its efficacy. The results of the post-trd polysomnogram were classified as follows: when the AHI with TRD was less than 10, the response was considered to be complete; when the AHI decreased by more than 50% and was less than 20 but greater than 10, the response was considered to be partial. Qu e s t i o n n a i r e A telephone questionnaire for the subjective evaluation of the efficacy and side effects of TRD was created for this work, inspired by questions used in previous studies. 9,15 (See Appendix.) From January to March 2007, patients and their bedpartners, when present, were systematically contacted by telephone by Journal of Clinical Sleep Medicine, Vol.5, No. 5,

3 Table 1 Characteristics of the Population with a Tongue-Retaining Device Initial Studied population population n = 107 n = 84 Sex: M/F, no. 85/22 64/20 Age at treatment initiation, y 55 ± ± 11.0 BMI, kg/m 2 27 ± ± 3.8 ESS score 9 ± ± 5 AHI, no./h 36 ± ± 19.5 Patients with severe OSAS, % Protrusion distance, mm 6.7 ± ± 1.5 Post-TRD AHI Tongue-Retaining Device in OSAS Data are shown as mean ± SD unless otherwise indicated. a single practitioner who verified that the questions were correctly understood. Because the practitioner was not in charge of these patients, his impartiality regarding their answers was ensured. Subjective Efficacy The efficacy or response obtained with TRD was subjectively evaluated in terms of the sound level of snoring by a visual analog score given to the bedpartner and, in terms of daytime sleepiness, by the ESS. Compliance and Tolerance Patients were classified as TRD users, defined by even sparse use at the time of the telephone call, or nonusers, if the treatment had been completely interrupted by this time. Compliance was also evaluated by the number of nights of TRD use and the duration of use per night (all night, more than half the night, less than half the night). Patients reported the most frequent side effects seen with oral appliances, in addition to reasons for noncompliance. Esthetic problems were included on the list of reasons, considering the singular design of the TRD. Statistical Methods Data are presented as percentages or as means ± standard deviation (SD). Event frequencies were compared using the χ² test or, when numbers were small, the Fisher exact test. The paired t test was used to study objective effectiveness. The Wilcoxon test was used to assess modifications of the visual analog score and the ESS score. We started by using logistic-regression models to select potential covariates, after making adjustments for survey year and some individual characteristics in cycle 4 (age, sex, vital risk, eg, arterial hypertension, heart disease, diabetes, and hypercholesterolemia). We then included all the variables in a multivariate analysis using logistic-regression models to estimate the association between clinical characteristics and efficacy on the one hand and tolerance on the other. All independent variables showing a univariate association with efficacy or tolerance with a p value less than 0.25 were introduced into the regression model and then subjected to backward selection. Decisions concerning potential covariates for the final model (p < 0.05) were based on the Hosmer and Lemeshow approach. Clinical predictors for efficacy and compliance were thus pinpointed Figure 2 Objective assessment of the tongue-retaining device (TRD) by the apnea-hypopnea index (AHI) (n = 55). The diagonal represents an absence of modification of the AHI, points below show a decrease in the AHI, and points above an increase in the AHI with TRD. The dotted line indicates an AHI of 10, ie, a complete response (47% of the cases). The 2 patients in whom the AHI was worse with TRD (empty circles) were users until the post- TRD polysomnogram was carried out. Following the polysomnography results, which indicated an obvious deleterious effect of the device, treatment was stopped. RESULTS Among the 84 patients studied, 55 (65%) underwent the outcome polysomnogram, 63 (75%) answered the telephone questionnaire, and 34 (40%) did both. Population Characteristics In Table 1, the characteristics of the initial population (n = 107) and the selected patients (n = 84) are compared. The 2 populations were not statistically different (χ² test). The mean and median follow-up time was identical for the 84 patients: 5 ± 2.0 years (range: ). TRD Efficacy Pre-TRD AHI Pr e-trd a n d Po s t-trd Po ly s o m n o g r a p h y Efficacy was objectively evaluated by comparing the AHI before and during TRD use in 55 patients (Figure 2). The group included both users and nonusers because some patients may have interrupted TRD use after the post-trd polysomnogram. A modification of protrusion distance (2-4 adjustments) was carried out in 4 patients. The post-trd polysomnogram taken into consideration took place after these adjustments. All but 4 patients displayed a lower AHI while using the TRD; 2 patients had a higher AHI and 2 did not show any change (AHI of 18 and 20, respectively). A response was obtained in 71% of the cases (39 patients); it was complete in 47% (26 patients) and partial in 24% (13 patients). If we assume that Journal of Clinical Sleep Medicine, Vol.5, No. 5,

4 DS Lazard, M Blumen, P Lévy et al Visual analogic score of snoring the 29 patients who did not undergo the post-trd polysomnogram were nonresponders and include them in the total number of patients assessed, efficacy response was obtained in 39 of 84 cases (47%), being complete in 26 of 84 cases (31%) and partial in 13 of 84 cases (15.5%). The AHI (n = 55) decreased significantly from 38 ± 22.2 to 14 ± 13.2, corresponding to a mean decrease of 27 ± 21.3 (p < 0.001, paired t test) with the TRD. Other indices decreased as follows: the apnea index (n = 48) from 23 ± 22.4 to 5 ± 9.1 (p < 0.001) and the hypopnea index (n = 48) from 17 ± 14.7 to 8 ± 6.1 (p < 0.001). Sn o r i n g Before TRD While using the TRD Figure 3 Individual visual analog scores indicating snoring before and during tongue-retaining device (TRD) use (n = 39). The figure shows a significant decrease in the intensity of snoring with the TRD (68%, p < ). Among the 63 patients who answered the questionnaire, 39 had a bedpartner capable of quantifying snoring in the presence or absence of the TRD (Figure 3). All bedpartners estimated that the level of snoring was reduced, except in 1 case, in which it was unchanged. The mean visual analog score without TRD was 8 ± 1.5 out of 10. It decreased to 3 ± 2.0 with TRD use, ie, a decrease of 68% in the intensity of snoring (p < , Wilcoxon test). others parameters tested (sex, smoking, nasal obstruction, sizes of the mobile tongue and base of the tongue, size of the tonsils, soft palate thickness, and uvula length) were not significantly correlated with efficacy (data not shown). No predictive value could be discerned for the severity of the OSAS (AHI > 30 or ESS score > 11), a pathologic body mass index (BMI 25 kg/ m 2 ), or an indication for TRD as a first- or second-line treatment after CPAP. The graphic analysis of the 2 significant variables age and protrusion distance allowed us to determine 2 cutoff points: an age of more than 60 years and a protrusion distance of less than 7 mm. Taking these thresholds into consideration, we transformed the 2 variables into a binary composite variable. We found that an age greater than 60 years associated with a protrusion distance inferior or equal to 7 mm was predictive of nonresponse (odds ratio [OR]: 7.25; 95% confidence interval [CI]: ; p = 0.016). TRD Compliance and Side Effects TRD Use Evaluated by a Telephone Questionnaire There were 33 users (52%) and 30 nonusers (48%) after a mean follow-up period of 5 years. These 2 groups were not statistically different, especially in terms of BMI (27.3 ± 4.2 kg/ m² for users, 27.2 ± 4.1 kg/m² for nonusers) and severity of the disease (AHI = 37.5 ± 18.1 for users, 36.1 ± 18.3 for nonusers). If we included patients who did not answer the questionnaire as nonusers (n = 21), the compliance rate decreased to 39%. Twenty-nine patients (46%) refused an objective assessment of TRD efficacy by means of the post-trd polysomnogram. These included 10 users (30%) and 19 nonusers (63%). Nonusers were significantly more reluctant to undergo the exam than were users (p < 0.01, χ² test). Users wore the TRD more than 4 nights per week in 79% of the cases and more than half the night in 86% of the cases. In nonusers, the trial lasted from less than 1 month (8 patients) to 36 months. The median and mean trial periods were 5 and 11 months (± 13.4), respectively. Among nonusers, 47% went back to CPAP, 41% had untreated OSAS, and 12% tried another type of appliance with satisfaction. Daytime Sleepiness The comparison of the ESS scores before and during TRD use was established for 24 patients. The ESS score decreased with TRD use from 9 ± 5.0 to 6 ± 3.7 (p < 0.05, Wilcoxon test). Five out of the 24 patients (21%) reported an increase in somnolence. Among these 24 patients, only 2 were nonusers, who stopped use just before the telephone inquiry. They wore the device for 18 and 36 months, respectively, and stopped for esthetic reasons in the first case and due to weight loss that led to remission of the OSAS in the other case. Their ESS scores decreased from 20 to 7 and from 13 to 4, respectively. Clinical Predictors of Efficacy After 4 cycles of multiple regression, 2 variables were found to be significant (p < 0.05): age and protrusion distance. The Reasons for Stopping TRD Use The main reasons for discontinuing TRD use reported by nonusers (n = 35 answers in total; 2 causes each were cited in 5 cases) were discomfort or sensation of a foreign body (49%), pain (31%), excessive salivation (8%), excessive mouth dryness (3%), and esthetic reasons (3%). No justification was given in 6% of the cases, and no technical difficulties were reported. Figure 4 shows the evolution of user and nonuser populations with time and the main causes of interruption reported by nonusers (n = 30). The majority of interruptions occurred within the first 6 months (60%). They then decreased and peaked again after 30 months. In the first 6 months, the most common reported reason for stopping TRD use was discomfort. Pain could be divided into 2 categories: pain early in use leading to interruption within the first 6 months, and chronic pain leading to interruption after a period of 30 months. Journal of Clinical Sleep Medicine, Vol.5, No. 5,

5 Tongue-Retaining Device in OSAS Numberof patients Users Non-users: Other Excessive salivation Pain Discomfort Months Figure 4 Evolution of the number of users and nonusers over time, and principal cause of treatment failure (first of 2 possible answers). The term Other groups dryness, esthetic reasons, and unjustified cases (n = 2). No withdrawals were recorded after 36 months. Among the 18 patients who discontinued use within the first 6 months, 8 stopped within the first month. Clinical Predictors of Compliance From a comparison of the clinical examination of users and nonusers, the presence of a nasal obstruction (anatomic or secondary to allergic rhinitis) was a negative predictor of good compliance (OR: 6.94; 95% CI: ; p = 0.008). A nasal obstruction was present in 69% of the patients who stopped wearing the TRD due to discomfort. In contrast, patients presenting with a Class I occlusion were more compliant than those with a Class II or III occlusion (OR: 3.83; 95% CI: ; p < 0.05). The other parameters tested (sex, age, smoking, sizes of the mobile tongue and base of the tongue, size of the tonsils, soft palate thickness, uvula length, and protrusion distance) were not found to be significantly correlated with compliance (data not shown). Neither OSAS severity (AHI > 30 or ESS score > 11) nor a pathologic BMI ( 25 kg/m 2 ) was predictive. Side Effects Figure 5 shows the distribution of side effects among users and nonusers. The 2 groups both reported more than 1 side effect. Users complained most about discomfort and excessive salivation. They presented no side effects in 30% of the cases. Compared with users, a higher proportion of nonusers complained about discomfort (p < 0.05, Mann Whitney test). It was considered a side effect and not a reason for discontinuing TRD use. Unfavorable dental modifications (position of the incisors) or parodontopathy while using the TRD were cited by 16% of all treated patients. Dental modifications were considered by patients to be minor. Dental modifications and parodontopathy were associated in 1 user. DISCUSSION This study reports long-term (39 months) TRD efficacy and tolerance in a relatively large population (n = 84). As previous- ly published, adequate medical follow-up of patients suffering from chronic diseases is difficult to achieve 2 : from the initial pool of 107 patients using the TRD, 21% were lost to followup, and 28% did not undergo the post-trd polysomnogram. Because the MAD is the most commonly used appliance in the treatment of OSAS 2, TRD outcomes will be compared with data provided for MAD in the literature. The characteristics and follow-up of our population were similar to that of the populations analyzed for MAD validation in previous studies. 2,15,16 Efficacy Considering the results of the outcome polysomnogram, the TRD was found to be effective in 71% of the cases studied. Similar results have been reported previously for TRD, 3-8 although for shorter trial periods, and for MAD 15,16 over comparable followup times. The fact that the AHI increased in 2 patients underlines the need for objective controls for the evaluation of any kind of OSAS treatment. The effect of TRD on subjective estimations of snoring (a decrease of 68%) was significant and, in particular, better than that reported for MAD (a decrease of 45%-50%). 2,9 The effect on daytime sleepiness was also significant, with an improvement in daytime symptoms comparable to that seen with MAD. 2,9 The assumption that patients who did not undergo the post- TRD polysomnography had discontinued treatment results in a drastic decrease in efficacy (47% vs 71%). Yet, we know from questioning patients that some of them were satisfied with the TRD but did not want to undergo the post-trd polysomnogram for other reasons or that they stopped because of side effects and not due to a lack of response. Compliance Because the principal indication for treatment with TRD in our series was CPAP intolerance, the population studied should Journal of Clinical Sleep Medicine, Vol.5, No. 5,

6 DS Lazard, M Blumen, P Lévy et al * Users Numberof patients Non-users None Discomfort Excessive salivation Mouth dryness Dental modifications Parondothopathy Figure 5 Side effects reported by users and nonusers. Two or more side effects were reported in 11 patients from each group. These side effects were not listed by nonusers as a reason for stopping use of the tongue-retaining device (TRD). * = p < 0.05 for discomfort in users vs nonusers. be considered to be biased, since patients were selected following the failure of an initial treatment and were less tolerant of the side effects of a new therapy. Nevertheless, the compliance rate after 5 years (52% of users) was quite good considering the rate of interruption within the first month (74%) previously reported for TRD. 7 This compliance rate was similar to the compliance rate for MAD (55% 9-64%). 15 The absence of a difference between users and nonusers in terms of BMI or of disease severity supports the idea that these factors do not influence tolerance, 15 regardless of the appliance being used. In the case of MAD, De Almeida and colleagues 15 estimated that the compliance rate decreases to 30% if nonresponders to questionnaires are considered to be nonusers. For TRD, the compliance rate decreases to 39% when including these patients. However, in our protocol, patients were systematically contacted by telephone, whereas the MAD surveys were carried out with mail-in questionnaires. 9,15 As a result, we may have collected more answers from dissatisfied nonusers who might not have taken the time to fill out a written questionnaire. Daily compliance by TRD users (79%) was close to that of MAD users 15 (92%) when applying the same criterion of use (ie, more often than 4 nights per week). The proportion of users using TRD for more than half the night was 86%, versus 100% for MAD. 15 Side Effects One third of TRD users experienced no side effects. For MAD, the reported rate is 50%. 15 Again, a bias with respect to the questionnaires cannot be excluded. The main reason given by nonusers for discontinuing TRD use was discomfort (48%), which was also the reason cited for MAD (44% 15-52% 9 ). The particular design of the TRD may explain the chronic tongue pain that led to late interruption (> 30 months). Interestingly, even though the tongue remains free within the mouth when using the MAD, tongue discomfort was also cited by patients who discontinued this treatment (up to 24%). 15 As in the case of MAD, discontinuation occurred mainly during the first 6 months. 15 Minor and temporary side effects as well as severe side effects that induced an interruption of treatment were the same for both TRD and MAD. 17 They were more related to oral appliances in general than to the particular design of the oral appliance. The number of unfavorable teeth modifications or parodontopathies with the TRD may have been underestimated, as there was no systematic dental control during our study. Thanks to stone casts, unfavorable changes were recorded in 44% of the cases with MAD. 18 In the future, dental position should be systematically and carefully documented before and during the use of an oral appliance. Clinical Predictors of TRD Efficacy and Tolerance Age greater than 60 years associated with a protrusion distance inferior or equal to 7 mm was found to be a negative clinical predictor of efficacy. With aging, oropharyngeal tissues may become more sensitive to negative pressure during apneas. As a consequence, a larger protrusion threshold (> 7 mm) should be applied in the case of patients older than 60 years. As with other types of appliances, 9,15 age, BMI, sex and daytime sleepiness were not predictive of tolerance. The negative and positive clinical predictors nasal obstruction and Class I occlusion, respectively might help enhance TRD tolerance if looked for during the initial examination. One-piece appliances like the TRD, by totally obstructing the mouth, impose nearly exclusive nasal respiration, which is difficult in patients who have nasal obstruction. The correlation between nasal obstruction and the sensation of discomfort could be related to an unconscious limitation of nasal respiratory airflow. Patients with Class II occlusions would have to undergo greater strain to benefit from (1) mandibular advancement, because it may induce more functional stress on the masticator muscles and temporomandibular joints, 19,20 and (2) lingual protraction, since tongue posture may be more posterior and Journal of Clinical Sleep Medicine, Vol.5, No. 5,

7 Tongue-Retaining Device in OSAS inferior, as described in cases of micrognathia (Treacher Collins and Nager syndromes). 21 To our knowledge, no study of MAD considers predictors of tolerance based on a global clinical examination to determine the best type of appliance to use according to the patient s clinical profile. Cost and Fabrication The cost of the TRD is about 500 Euros, including adjustments, versus 400 to 600 Euros for the MAD in France. Nevertheless, its infrequent prescription by practitioners may be explained by the fact that it is more laborious and time consuming to make. CONCLUSION The TRD was shown to be effective objectively and subjectively, and compliance within the population studied was found to be quite good. Nevertheless, if patients who did not respond to an objective (34.5%) or subjective control (25%) are classified as nonusers, the benefits of this appliance become arguable. Taking nasal obstruction into account as a contraindication to TRD should permit us to avoid an important factor in treatment failure. TRD may be proposed as one of the alternatives to CPAP by teams trained in its fabrication and accommodation. Clinical predictors of tolerance for the MAD should also be investigated to define an anatomic profile of patients best suited to each device. Acknowledgments The authors want to thank Hernan Castro, without whose help and tenacity in studying the charts, this work could not have been done. Anne Moore was of great help in preparing this manuscript. We are also especially grateful to Evelyne Ferrary for her valuable comments. Disclosure Statement This was not an industry supported study. The authors have indicated no financial conflicts of interest. REFERENCES 1. Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for Sleep 2006;29: Hoffstein V. Review of oral appliances for treatment of sleepdisordered breathing. Sleep Breath 2007;11: Cartwright RD, Samelson CF. The effects of a nonsurgical treatment for obstructive sleep apnea. The tongue-retaining device. Jama 1982;248: Cartwright R, Stefoski D, Caldarelli D, et al. Toward a treatment logic for sleep apnea: the place of the tongue retaining device. Behav Res Ther 1988;26: Kingshott RN, Jones DR, Taylor DR, Robertson CJ. The efficacy of a novel tongue-stabilizing device on polysomnographic variables in sleep-disordered breathing: a pilot study. Sleep Breath 2002;6: Ono T, Lowe AA, Ferguson KA, Fleetham JA. A tongue retaining device and sleep-state genioglossus muscle activity in patients with obstructive sleep apnea. Angle Orthod 1996;66: Schonhofer B, Stoohs RA, Rager H, Wenzel M, Wenzel G, Kohler D. A new tongue advancement technique for sleep-disordered breathing: side effects and efficacy. Am J Respir Crit Care Med 1997;155: Barthlen GM, Brown LK, Wiland MR, Sadeh JS, Patwari J, Zimmerman M. Comparison of three oral appliances for treatment of severe obstructive sleep apnea syndrome. Sleep Med 2000;1: McGown AD, Makker HK, Battagel JM, L Estrange PR, Grant HR, Spiro SG. Long-term use of mandibular advancement splints for snoring and obstructive sleep apnoea: a questionnaire survey. Eur Respir J 2001;17: Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22: Ferber R, Millman R, Coppola M, et al. Portable recording in the assessment of obstructive sleep apnea. ASDA standards of practice. Sleep 1994;17: Cartwright R, Ristanovic R, Diaz F, Caldarelli D, Alder G. A comparative study of treatments for positional sleep apnea. Sleep 1991;14: Clark GT, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996;109: O Sullivan RA, Hillman DR, Mateljan R, Pantin C, Finucane KE. Mandibular advancement splint: an appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 1995;151: de Almeida FR, Lowe AA, Tsuiki S, et al. Long-term compliance and side effects of oral appliances used for the treatment of snoring and obstructive sleep apnea syndrome. J Clin Sleep Med 2005;1: Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 2004;125: Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006;29: Almeida FR, Lowe AA, Otsuka R, Fastlicht S, Farbood M, Tsuiki S. Long-term sequellae of oral appliance therapy in obstructive sleep apnea patients: Part 2. Study-model analysis. Am J Orthod Dentofacial Orthop 2006;129: Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002;121: George PT. Selecting sleep-disordered-breathing appliances. Biomechanical considerations. J Am Dent Assoc 2001;132: Heller JB, Gabbay JS, Kwan D, et al. Genioplasty distraction osteogenesis and hyoid advancement for correction of upper airway obstruction in patients with Treacher Collins and Nager syndromes. Plast Reconstr Surg 2006;117: Journal of Clinical Sleep Medicine, Vol.5, No. 5,

8 DS Lazard, M Blumen, P Lévy et al Telephone Questionnaire Appendix 1. Do you still use the TRD? - Yes/No 2. If you still use the TRD, what is your compliance rate? - Do you use it more or less than 4 nights per week? - Do you use it all night, more than half the night, or less than half the night? 3. If you have discontinued use, how long did the trial last (in months)? 4. Please indicate 1 or 2 reasons for stopping TRD use among the following: - Esthetic - Pain. If yes, please indicate the localization: tongue, masticator muscles, temporomandibular joint, teeth, or gums - Excessive salivation - Mouth dryness - Technical difficulties - Discomfort due to the sensation of a foreign body - Other 5. Whatever your user status, did you experience any of the following? - Discomfort - Excessive salivation - Mouth dryness - Subjective feeling of dental modifications - Periodontal diseases 6. Can your bedpartner evaluate the level of snoring with the TRD using a visual analog score from 0 to 10? Scoring was explained. 7. What is your ESS score while using the TRD? The Epworth Sleepiness Scale was read out to patients and the score calculated on the spot. 8. Did you undergo the outcome PSG? - Yes/No. If no, was it because of a refusal to undergo the PSG? Journal of Clinical Sleep Medicine, Vol.5, No. 5,

Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea European Journal of Orthodontics 20 (1998) 293 297 1998 European Orthodontic Society Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea J. Lamont*, D. R. Baldwin**,

More information

RESEARCH PACKET DENTAL SLEEP MEDICINE

RESEARCH PACKET DENTAL SLEEP MEDICINE RESEARCH PACKET DENTAL SLEEP MEDICINE American Academy of Dental Sleep Medicine Dental Sleep Medicine Research Packet Page 1 Table of Contents Research: Oral Appliance Therapy vs. Continuous Positive Airway

More information

Long-term use of mandibular advancement splints for snoring and obstructive sleep apnoea: a questionnaire survey

Long-term use of mandibular advancement splints for snoring and obstructive sleep apnoea: a questionnaire survey Eur Respir J 2001; 17: 462 466 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 Long-term use of mandibular advancement splints for snoring

More information

The Mandibular Advancement Device and Patient Selection in the Treatment of Obstructive Sleep Apnea

The Mandibular Advancement Device and Patient Selection in the Treatment of Obstructive Sleep Apnea ORIGINAL ARTICLE The Mandibular Advancement Device and Patient Selection in the Treatment of Obstructive Sleep Apnea Chul Hee Lee, MD; Ji-Hun Mo, MD; Ik-Joon Choi, MD; Hyun Jong Lee, MD; Beom Seok Seo,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Marklund M, Carlberg B, Forsgren L, Olsson T, Stenlund H, Franklin KA. Oral appliance therapy in patients with daytime sleepiness and snoring or mild to moderate sleep apnea:

More information

Oral Appliances and their Clinical Applications

Oral Appliances and their Clinical Applications Oral Appliances and their Clinical Applications Peter Cistulli MBBS, PhD, MBA, FRACP Professor of Respiratory Medicine & Head of Discipline of Sleep Medicine University of Sydney Director, Centre for Sleep

More information

Management of OSA. saurabh maji

Management of OSA. saurabh maji Management of OSA saurabh maji INTRODUCTION Obstructive sleep apnea is a major public health problem Prevalence of OSAS in INDIA is 2.4% to 4.96% in men and 1% to 2 % in women In the rest of the world

More information

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders Center 415-885-7886 Disclosures: None Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs)

More information

Comprehensive care of any disease requires expertise in

Comprehensive care of any disease requires expertise in Otolaryngology Head and Neck Surgery (2010) 143, 78-84 ORIGINAL RESEARCH SLEEP MEDICINE Otolaryngology office-based treatment of obstructive sleep apnea-hypopnea syndrome with titratable and nontitratable

More information

Mandibular repositioning appliance (MRA) therapy for snoring

Mandibular repositioning appliance (MRA) therapy for snoring Scientific investigations Effect of a Titration Polysomnogram on Treatment Success with a Mandibular Repositioning Appliance Fernanda R. Almeida, D.D.S. 1 ; Jonathan A. Parker, D.D.S. 2 ; James S. Hodges,

More information

The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea*

The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea* The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea* Marie Marklund, DDS; Karl A. Franklin, MD, PhD, FCCP; Carin Sahlin, RTA; and Rune Lundgren, MD,

More information

Dental Appliance Treatment for Obstructive Sleep Apnea* Andrew S. L. Chan, MBBS; Richard W. W. Lee, MBBS; and Peter A. Cistulli, MBBS, PhD, FCCP

Dental Appliance Treatment for Obstructive Sleep Apnea* Andrew S. L. Chan, MBBS; Richard W. W. Lee, MBBS; and Peter A. Cistulli, MBBS, PhD, FCCP CHEST Dental Appliance Treatment for Obstructive Sleep Apnea* Andrew S. L. Chan, MBBS; Richard W. W. Lee, MBBS; and Peter A. Cistulli, MBBS, PhD, FCCP Postgraduate Education Corner CONTEMPORARY REVIEWS

More information

Oral Appliances and their Clinical Indications in OSA

Oral Appliances and their Clinical Indications in OSA Oral Appliances and their Clinical Indications in OSA Disclosures Andrew Chan, MB BS, PhD, FRACP, FCCP Staff Specialist, Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, University

More information

Oral appliance treatment of obstructive sleep apnea: an update Andrew S.L. Chan a,b and Peter A. Cistulli a,b

Oral appliance treatment of obstructive sleep apnea: an update Andrew S.L. Chan a,b and Peter A. Cistulli a,b Oral appliance treatment of obstructive sleep apnea: an update Andrew S.L. Chan a,b and Peter A. Cistulli a,b a Centre for Sleep Health and Research, Department of Respiratory Medicine, Royal North Shore

More information

clinical investigations Evaluation of Variable Mandibular Advancement Appliance for Treatment of Snoring and Sleep Apnea*

clinical investigations Evaluation of Variable Mandibular Advancement Appliance for Treatment of Snoring and Sleep Apnea* clinical investigations Evaluation of Variable Mandibular Advancement Appliance for Treatment of Snoring and Sleep Apnea* Jeffrey Pancer, DDS; Salem Al-Faifi, MD; Mohamed Al-Faifi, MD; and Victor Hoffstein,

More information

The role of oral appliance therapy in the treatment of obstructive sleep apnea

The role of oral appliance therapy in the treatment of obstructive sleep apnea Clin Chest Med 24 (2003) 355 364 The role of oral appliance therapy in the treatment of obstructive sleep apnea Kathleen A. Ferguson, MD, FRCPC, FCCP Division of Respirology, London Health Sciences Centre,

More information

Snoring And Sleep Apnea in the U.S. Definitions Apnea: Cessation of ventilation for > 10 seconds. Defining Severity of OSA

Snoring And Sleep Apnea in the U.S. Definitions Apnea: Cessation of ventilation for > 10 seconds. Defining Severity of OSA Snoring and Obstructive Sleep Apnea: Oral Appliance Therapy Management Midwest Society of Orthodontists October 16-17, 2009 Anthony J DiAngelis DMD, MPH Chief, Department of Dentistry, HCMC Professor,

More information

Investigation of positional and non-positional OSA: impact. on outcomes in patients treated with mandibular

Investigation of positional and non-positional OSA: impact. on outcomes in patients treated with mandibular Investigation of positional and non-positional OSA: impact on outcomes in patients treated with mandibular advancement devices Short title: Oral Appliances in positional and non-positional OSA JIN WOO

More information

SLEEP APNOEA DR TAN KAH LEONG ALVIN CO-DIRECTOR SLEEP LABORATORY SITE CHIEF SDDC (SLEEP) DEPARTMENT OF OTORHINOLARYNGOLOGY, HEAD & NECK SURGERY

SLEEP APNOEA DR TAN KAH LEONG ALVIN CO-DIRECTOR SLEEP LABORATORY SITE CHIEF SDDC (SLEEP) DEPARTMENT OF OTORHINOLARYNGOLOGY, HEAD & NECK SURGERY SLEEP APNOEA DR TAN KAH LEONG ALVIN CO-DIRECTOR SLEEP LABORATORY SITE CHIEF SDDC (SLEEP) DEPARTMENT OF OTORHINOLARYNGOLOGY, HEAD & NECK SURGERY

More information

An orthodontic oral appliance

An orthodontic oral appliance Original Article An orthodontic oral appliance A randomized, controlled pilot study Marie Marklund a ; Per Erik Legrell b ABSTRACT Objective: This pilot study was performed to test the hypothesis that

More information

Clinical Study Long Term Therapeutic Efficacy of a Soft Monobloc Mandibular Advancement Device in Adults with Obstructive Sleep Apnea

Clinical Study Long Term Therapeutic Efficacy of a Soft Monobloc Mandibular Advancement Device in Adults with Obstructive Sleep Apnea e Scientific World Journal Volume 2015, Article ID 408469, 6 pages http://dx.doi.org/10.1155/2015/408469 Clinical Study Long Term Therapeutic Efficacy of a Soft Monobloc Mandibular Advancement Device in

More information

Mandibular Advancement Device : Long-term Effects on Apnea and Sleep

Mandibular Advancement Device : Long-term Effects on Apnea and Sleep Mandibular Advancement Device With Obstructive Sleep Apnea * in Patients : Long-term Effects on Apnea and Sleep Marie Marklund, Carin Sahlin, Hans Stenlund, Maurits Persson and Karl A. Franklin Chest 2001;120;162-169

More information

Learning Objectives. And it s getting worse. The Big Picture. Dr. Roger Roubal

Learning Objectives. And it s getting worse. The Big Picture. Dr. Roger Roubal Learning Objectives How to screen for sleep apnea; questions to ask your patients Industry treatment guidelines; when to consider an oral appliance vs. a CPAP What goals/thresholds to set for successful

More information

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO

More information

11/19/2012 ก! " Varies 5-86% in men 2-57% in women. Thailand 26.4% (Neruntarut et al, Sleep Breath (2011) 15: )

11/19/2012 ก!  Varies 5-86% in men 2-57% in women. Thailand 26.4% (Neruntarut et al, Sleep Breath (2011) 15: ) Snoring ก Respiratory sound generated in the upper airway during sleep that typically occurs during inspiration but may occur during expiration ICSD-2, 2005..... ก ก! Prevalence of snoring Varies 5-86%

More information

Change of Obstruction Site by Modified Jaw Thrust Maneuver in Obstructive Sleep Apnea Patients

Change of Obstruction Site by Modified Jaw Thrust Maneuver in Obstructive Sleep Apnea Patients ORIGINAL ARTICLE pissn 2093-9175 / eissn 2233-8853 Sleep Med Res 2014;5(2):49-53 Change of Obstruction Site by Modified Jaw Thrust Maneuver in Obstructive Sleep Apnea Patients Soo-Kweon Koo, MD, PhD, Hyoung-Ju

More information

Sleep Medicine. Paul Fredrickson, MD Director. Mayo Sleep Center Jacksonville, Florida.

Sleep Medicine. Paul Fredrickson, MD Director. Mayo Sleep Center Jacksonville, Florida. Sleep Medicine Paul Fredrickson, MD Director Mayo Sleep Center Jacksonville, Florida Fredrickson.Paul@mayo.edu DISCLOSURES No relevant conflicts to report. Obstructive Sleep Apnea The most common sleep

More information

Prefabricated Oral Appliances for Obstructive Sleep Apnea

Prefabricated Oral Appliances for Obstructive Sleep Apnea Medical Policy Manual Allied Health, Policy No. 36 Prefabricated Oral Appliances for Obstructive Sleep Apnea Next Review: May 2019 Last Review: April 2018 Effective: May 1, 2018 IMPORTANT REMINDER Medical

More information

What is the Role of Soft Palate Surgery in OSA?

What is the Role of Soft Palate Surgery in OSA? What is the Role of Soft Palate Surgery in OSA? Edward M. Weaver, MD, MPH Seattle VA Medical Center University of Washington Harborview Medical Center Acknowledgments This material is the result of work

More information

BTS sleep Course. Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith)

BTS sleep Course. Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith) BTS sleep Course Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith) S1: Overview of OSA Definition History Prevalence Pathophysiology Causes Consequences

More information

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;

More information

THE ROLE OF THE MATRx IN PREDICTING WHICH PATIENTS CAN BE TREATED SUCCESSFULLY WITH ORAL APPLIANCES

THE ROLE OF THE MATRx IN PREDICTING WHICH PATIENTS CAN BE TREATED SUCCESSFULLY WITH ORAL APPLIANCES THE ROLE OF THE MATRx IN PREDICTING WHICH PATIENTS CAN BE TREATED SUCCESSFULLY WITH ORAL APPLIANCES Brock Rondeau, D.D.S. I.B.O., D.A.B.C.P., D-A.C.S.D.D., D.A.B.D.S.M., D.A.B.C.D.S.M. Oral appliance therapy

More information

K Don Bigelow DDS PC DASBA

K Don Bigelow DDS PC DASBA K Don Bigelow DDS PC DASBA Graduate Medical College of Virginia School of Dentistry Diplomate American Sleep and Breathing Academy AASM Dental Sleep Masters International Academy of Dental Sleep Utah Sleep

More information

Mandibular advancement device therapy in obstructive sleep apnea Aarab, G.

Mandibular advancement device therapy in obstructive sleep apnea Aarab, G. UvA-DARE (Digital Academic Repository) Mandibular advancement device in obstructive sleep apnea Aarab, G. Link to publication Citation for published version (APA): Aarab, G. (2011). Mandibular advancement

More information

The use of mandibular advancement devices for the treatment of Obstructive Sleep Apnea

The use of mandibular advancement devices for the treatment of Obstructive Sleep Apnea Review The use of mandibular advancement devices for the treatment of Obstructive Sleep Apnea Stavros Kiriopoulos 1, Dimosthenis Lykouras 2, Agathi Spiropoulou 2, Panagis Drakatos 3, Kiriakos Karkoulias

More information

Sleep disorder of the upper airway results from any

Sleep disorder of the upper airway results from any Original Article Role of Oral Appliances in the Management of Sleep Disorders Lt Col B Jayan *, Brig BNBM Prasad, SM, VSM +, Col RK Dhiman # Abstract Background: A study was undertaken with the aim to

More information

The use of an oral mandibular advancement device out of thermo flexible vinyl in connection with sleep related breathing disturbances.

The use of an oral mandibular advancement device out of thermo flexible vinyl in connection with sleep related breathing disturbances. The use of an oral mandibular advancement device out of thermo flexible vinyl in connection with sleep related breathing disturbances. J.T. Maurer, B. Werner, C. Juncker, F. Riedel, K. Hörmann Effectiveness

More information

Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea

Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea Original Article Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea Ahmad Khajeh-Mehrizi 1,2 and Omid Aminian 1 1. Occupational Sleep

More information

Emerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea

Emerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea Emerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea Sigma Theta Tau International 28th International Nursing Research Congress 27-31 July 2017

More information

Edward M. Weaver, MD, MPH. University of Washington VA Puget Sound

Edward M. Weaver, MD, MPH. University of Washington VA Puget Sound What is the Role of Soft Palate Surgery in OSA? Edward M. Weaver, MD, MPH University of Washington Harborview Medical Center VA Puget Sound Question: Should we do UPPP? Answer: Yes Role of Palate Surgery

More information

EXPLORE NEW POSSIBILITIES

EXPLORE NEW POSSIBILITIES EXPLORE NEW POSSIBILITIES TREATING SNORING AND SLEEP APNOEA HAS CHANGED FOREVER Introducing the Oventus O 2 Vent, a custom made, comfortable oral appliance with a unique airway design for the treatment

More information

European Journal of Orthodontics 27 (2005) European Journal of Orthodontics vol. 27 no. 1 doi: /ejo/cjh067

European Journal of Orthodontics 27 (2005) European Journal of Orthodontics vol. 27 no. 1 doi: /ejo/cjh067 European Journal of Orthodontics 27 (2005) 82 90 European Journal of Orthodontics vol. 27 no. 1 doi: 10.1093/ejo/cjh067 European Orthodontic Society 2005; all rights reserved. A comparison of the Twin

More information

Role of Oral Devices in Managing Sleep-disordered Breathing Patients

Role of Oral Devices in Managing Sleep-disordered Breathing Patients Role of Oral Devices in Managing Sleep-disordered Breathing Patients Sleep-disordered breathing (SDB) includes mouth breathing, snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnea

More information

Introduction OPT has been shown to effectively treat sleep apnea in about 40% of patients (Colrain IM et al. Sleep Medicine 14; , 2013)

Introduction OPT has been shown to effectively treat sleep apnea in about 40% of patients (Colrain IM et al. Sleep Medicine 14; , 2013) Oral Pressure Therapy for OSA Oral Pressure Therapy for OSA - Disclosures Richard J. Schwab, M.D. Professor of Medicine Division of Sleep Medicine Pulmonary, Allergy and Critical Care Division University

More information

Evaluation of Therapeutic Efficacy of Adjustable Mandibular Advancement Device in the Management of Obstructive Sleep Apnea

Evaluation of Therapeutic Efficacy of Adjustable Mandibular Advancement Device in the Management of Obstructive Sleep Apnea IJSM Evaluation of Therapeutic Efficacy of Adjustable Mandibular Advancement 10.5005/jp-journals-10069-0016 Device in the Management of OSA ORIGINAL ARTICLE Evaluation of Therapeutic Efficacy of Adjustable

More information

Selecting the Right Patients for Oral Appliance Therapy

Selecting the Right Patients for Oral Appliance Therapy Selecting the Right Patients for Oral Appliance Therapy AN OVERVIEW OF THE IN-LAB MATRx TITRATION SYSTEM Oral Appliance Titration Made Simple Confidently Prescribe Oral Appliance Therapy The ONLY validated

More information

Temperature controlled radiofrequency ablation for OSA

Temperature controlled radiofrequency ablation for OSA Temperature controlled radiofrequency ablation for OSA Ridhwan Y. Baba, M.B.B.S. *1, V.V.S. Ramesh Metta, M.B.B.S. 1, Arjun Mohan, M.B.B.S. 2, M. Jeffery Mador, M.D. 2 1 Department of Internal Medicine,

More information

Evaluation, Management and Long-Term Care of OSA in Adults

Evaluation, Management and Long-Term Care of OSA in Adults Evaluation, Management and Long-Term Care of OSA in Adults AUGUST 2015 Providing diagnostic tools and therapies that are evidence-based is a key part of a successful sleep practice. This resource outlines

More information

Sleep Disordered Breathing

Sleep Disordered Breathing Sleep Disordered Breathing SDB SDB Is an Umbrella Term for Many Disorders characterized by a lack of drive to breathe Results n repetitive pauses in breathing with no effort Occurs for a minimum of 10

More information

Sleep Diordered Breathing (Part 1)

Sleep Diordered Breathing (Part 1) Sleep Diordered Breathing (Part 1) History (for more topics & presentations, visit ) Obstructive sleep apnea - first described by Charles Dickens in 1836 in Papers of the Pickwick Club, Dickens depicted

More information

QUESTIONS FOR DELIBERATION

QUESTIONS FOR DELIBERATION New England Comparative Effectiveness Public Advisory Council Public Meeting Hartford, Connecticut Diagnosis and Treatment of Obstructive Sleep Apnea in Adults December 6, 2012 UPDATED: November 28, 2012

More information

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;

More information

Upper Airway Stimulation for Obstructive Sleep Apnea

Upper Airway Stimulation for Obstructive Sleep Apnea Upper Airway Stimulation for Obstructive Sleep Apnea Background, Mechanism and Clinical Data Overview Seth Hollen RPSGT 21 May 2016 1 Conflicts of Interest Therapy Support Specialist, Inspire Medical Systems

More information

Questions: What tests are available to diagnose sleep disordered breathing? How do you calculate overall AHI vs obstructive AHI?

Questions: What tests are available to diagnose sleep disordered breathing? How do you calculate overall AHI vs obstructive AHI? Pediatric Obstructive Sleep Apnea Case Study : Margaret-Ann Carno PhD, CPNP, D,ABSM for the Sleep Education for Pulmonary Fellows and Practitioners, SRN ATS Committee April 2014. Facilitator s guide Part

More information

Sleep Apnea. Herbert A Berger, MD Pulmonary Division Department of Internal Medicine University of Iowa

Sleep Apnea. Herbert A Berger, MD Pulmonary Division Department of Internal Medicine University of Iowa Sleep Apnea Herbert A Berger, MD Pulmonary Division Department of Internal Medicine University of Iowa Disclosures No Relevant Financial Interests to Report Objectives Learn the history and physical examination

More information

Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study

Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study bs_bs_banner ORIGINAL ARTICLE Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: An observational study ANIL ANANDAM, 1,2 MONALI PATIL,

More information

What is Oral Appliance Therapy?

What is Oral Appliance Therapy? You may have been diagnosed by your physician as required treatment for sleep-disordered breathing (snoring and/or obstructive sleep apnea). This condition may pose serious health risks since it disrupts

More information

Outline. Major variables contributing to airway patency/collapse. OSA- Definition

Outline. Major variables contributing to airway patency/collapse. OSA- Definition Outline Alicia Gruber Kalamas, MD Associate Clinical Professor of Anesthesia & Perioperative Care University of California, San Francisco September 2011 Definition Pathophysiology Patient Risk Factors

More information

UPDATES IN SLEEP APNEA:

UPDATES IN SLEEP APNEA: UPDATES IN SLEEP APNEA: CPAP,CPAP COMPLIANCE, & ALTERNATIVES MICHELLE ZETOONY, DO, FCCP, FACOI BOARD CERTIFIED PULMONARY, CRITICAL CARE, SLEEP & INTERNAL MEDICINE CLEARWATER, FL DISCLOSURE I have no conflicts

More information

Influence of Sleep Posture on Response to Oral Appliance Therapy for Sleep Apnea Syndrome

Influence of Sleep Posture on Response to Oral Appliance Therapy for Sleep Apnea Syndrome SLEEP-RELATED BREATHING DISORDERS Influence of Sleep Posture on Response to Oral Appliance Therapy for Sleep Apnea Syndrome Kazuya Yoshida DDS, PhD Department of Oral and Maxillofacial Surgery, Graduate

More information

Sleep Apnea: Diagnosis & Treatment

Sleep Apnea: Diagnosis & Treatment Disclosure Sleep Apnea: Diagnosis & Treatment Lawrence J. Epstein, MD Sleep HealthCenters Harvard Medical School Chief Medical Officer for Sleep HealthCenters Sleep medicine specialty practice group Consultant

More information

Obstructive sleep apnea (OSA) is a common disorder

Obstructive sleep apnea (OSA) is a common disorder Original Research Sleep Medicine and Surgery Drug-Induced Sedation Endoscopy in the Evaluation of OSA Patients with Incomplete Oral Appliance Therapy Response Otolaryngology Head and Neck Surgery 2015,

More information

ORIGINAL ARTICLE. for mild to moderate obstructive

ORIGINAL ARTICLE. for mild to moderate obstructive ORIGINAL ARTICLE An Investigation of Upper Airway Changes Associated With Mandibular Advancement Device Using Sleep Videofluoroscopy in Patients With Obstructive Sleep Apnea Chul Hee Lee, MD, PhD; Jeong-Whun

More information

Surgical Options for the Successful Treatment of Obstructive Sleep Apnea

Surgical Options for the Successful Treatment of Obstructive Sleep Apnea Surgical Options for the Successful Treatment of Obstructive Sleep Apnea Benjamin J. Teitelbaum, MD, FACS Otolaryngology Head and Neck Surgery Saint Agnes Medical Center Fresno, California Terms Apnea

More information

Polysomnography (PSG) (Sleep Studies), Sleep Center

Polysomnography (PSG) (Sleep Studies), Sleep Center Policy Number: 1036 Policy History Approve Date: 07/09/2015 Effective Date: 07/09/2015 Preauthorization All Plans Benefit plans vary in coverage and some plans may not provide coverage for certain service(s)

More information

Comparing Upper Airway Stimulation to Expansion Sphincter Pharyngoplasty: A Single University Experience

Comparing Upper Airway Stimulation to Expansion Sphincter Pharyngoplasty: A Single University Experience 771395AORXXX10.1177/0003489418771395Annals of Otology, Rhinology & LaryngologyHuntley et al research-article2018 Original Article Comparing Upper Airway Stimulation to Expansion Sphincter Pharyngoplasty:

More information

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016 Obstructive Sleep Apnea and COPD overlap syndrome Chitra Lal, MD, FCCP, FAASM Associate Professor of Medicine, Pulmonary, Critical Care, and Sleep, Medical University of South Carolina Financial Disclosures

More information

Effect of Three Different Mandibular Advancement Devices and Two Different Bite Techniques on the Resultant Sleep Metrics

Effect of Three Different Mandibular Advancement Devices and Two Different Bite Techniques on the Resultant Sleep Metrics Effect of Three Different Mandibular Advancement Devices and Two Different Bite Techniques on the Resultant Sleep Metrics Shamshudin (Sam) Kherani, DDS, FAGD, MICCMO Background It has been documented in

More information

ORAL APPLIANCE THERAPY

ORAL APPLIANCE THERAPY ORAL APPLIANCE THERAPY IN AND OUT OF LAB Todd Wyatt, DMD Background in Sleep Tim C Duke DDS Respironics SomnoMed Elite Somcenter Sleep Centers of Arkansas WCMC (Unity Health) Baptist Health ResMed American

More information

Efficacy and mechanism of mandibular advancement devices for persistent sleep apnea after surgery: a prospective study

Efficacy and mechanism of mandibular advancement devices for persistent sleep apnea after surgery: a prospective study Luo et al. Journal of Otolaryngology - Head and Neck Surgery (2016) 45:56 DOI 10.1186/s40463-016-0167-x ORIGINAL RESEARCH ARTICLE Open Access Efficacy and mechanism of mandibular advancement devices for

More information

Anyone of any shape or size may snore, but there are certain features which significantly increase the chance of snoring.

Anyone of any shape or size may snore, but there are certain features which significantly increase the chance of snoring. Snoring Snoring is a common sleep related problem affecting more than 20% of the population at some stage in their lives. Snoring occurs when various parts of the throat, including the soft palate, tonsils

More information

Mandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes?

Mandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes? NoSnores Mandibular Advancement Device (mouthguard) for Snoring & Sleep Apnea CLINICAL REFERENCES J Clin Sleep Med. 2013 Sep;9(9):971-2. doi: 10.5664/jcsm.3008. Mandibular Advancement Device vs CPAP in

More information

Treatment of Obstructive Sleep Apnea (OSA)

Treatment of Obstructive Sleep Apnea (OSA) MP9239 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below None Prevea360 Health Plan Medical Policy: 1.0 A continuous positive airway

More information

Christopher D. Turnbull 1,2, Daniel J. Bratton 3, Sonya E. Craig 1, Malcolm Kohler 3, John R. Stradling 1,2. Original Article

Christopher D. Turnbull 1,2, Daniel J. Bratton 3, Sonya E. Craig 1, Malcolm Kohler 3, John R. Stradling 1,2. Original Article Original Article In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP Christopher D. Turnbull

More information

IEHP considers the treatment of obstructive sleep apnea (OSA) medically necessary according to the criteria outlined below:

IEHP considers the treatment of obstructive sleep apnea (OSA) medically necessary according to the criteria outlined below: : Positive Airway Pressure, Oral Appliances, and Surgical Interventions Policy: Obstructive sleep apnea (OSA) is characterized by an interruption of breathing during sleep most commonly due to extra or

More information

Brian Palmer, D.D.S, Kansas City, Missouri, USA. April, 2001

Brian Palmer, D.D.S, Kansas City, Missouri, USA. April, 2001 Brian Palmer, D.D.S, Kansas City, Missouri, USA A1 April, 2001 Disclaimer The information in this presentation is for basic information only and is not to be construed as a diagnosis or treatment for any

More information

Annals and Essences of Dentistry

Annals and Essences of Dentistry ROLE OF ORAL APPLIANCE IN CLINICAL MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA IN CHILDREN * Balaji K, ** Tarasingh P * Associate Professor ** Asst. Professor Dept of Pedodontics and Preventive Dentistry, SVS

More information

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome Natsios Georgios University Hospital of Larissa, Greece Definitions Obstructive Sleep Apnea (OSA)

More information

In-Patient Sleep Testing/Management Boaz Markewitz, MD

In-Patient Sleep Testing/Management Boaz Markewitz, MD In-Patient Sleep Testing/Management Boaz Markewitz, MD Objectives: Discuss inpatient sleep programs and if they provide a benefit to patients and sleep centers Identify things needed to be considered when

More information

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders Center 415-885-7886 Disclosres: None Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs)

More information

The Agony or the Ecstasy. Familiar?

The Agony or the Ecstasy. Familiar? The Agony or the Ecstasy Familiar? Snoring Related Complaints Drives wife from bedroom Girlfriend won t marry me Shakes entire house Ask me to leave movies and church Has had to leave boat so friends could

More information

Shyamala Pradeepan. Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle.

Shyamala Pradeepan. Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle. Shyamala Pradeepan Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle. What is sleep apnoea?? Repetitive upper airway narrowing

More information

A First Line Treatment for Sleep Disordered Breathing

A First Line Treatment for Sleep Disordered Breathing A First Line Treatment for Sleep Disordered Breathing Sleep Disordered Breathing Snoring & Obstructive Sleep Apnoea Snoring and Obstructive Sleep Apnoea (OSA) are caused by the airway narrowing or even

More information

A Winning Combination

A Winning Combination The Physiologic Sleep Bite and the Micr0 2 Sleep Device A Winning Combination There is no doubt that using the best bite technique available will improve overall treatment success, but how important is

More information

Management of OSA in the Acute Care Environment. Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018

Management of OSA in the Acute Care Environment. Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018 Management of OSA in the Acute Care Environment Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018 1 Learning Objectives Upon completion, the participant should be able to: Understand pathology

More information

Prediction of sleep-disordered breathing by unattended overnight oximetry

Prediction of sleep-disordered breathing by unattended overnight oximetry J. Sleep Res. (1999) 8, 51 55 Prediction of sleep-disordered breathing by unattended overnight oximetry L. G. OLSON, A. AMBROGETTI ands. G. GYULAY Discipline of Medicine, University of Newcastle and Sleep

More information

Alexandria Workshop on

Alexandria Workshop on Alexandria Workshop on 1 Snoring & OSA Surgery Course Director: Yassin Bahgat MD Claudio Vicini MD Course Board: Filippo Montevecchi MD Pietro Canzi MD Snoring & Obstructive ti Sleep Apnea The basic information

More information

Effects of an oral appliance with different mandibular protrusion positions at a constant vertical dimension on obstructive sleep apnea

Effects of an oral appliance with different mandibular protrusion positions at a constant vertical dimension on obstructive sleep apnea Clin Oral Invest (2010) 14:339 345 DOI 10.1007/s00784-009-0298-9 ORIGINAL ARTICLE Effects of an oral appliance with different mandibular protrusion positions at a constant vertical dimension on obstructive

More information

Did you know more than a million Australians suffer from severe sleep apnoea?

Did you know more than a million Australians suffer from severe sleep apnoea? Did you know more than a million Australians suffer from severe sleep apnoea? Your comprehensive guide to curing sleep apnoea www.futuredental.com.au 1 Contents What is Obstructive Sleep Apnoea? 2 What

More information

Obstructive Sleep Apnea Syndrome. Common sleep disorder causes high blood pressure and heart attacks

Obstructive Sleep Apnea Syndrome. Common sleep disorder causes high blood pressure and heart attacks Obstructive Sleep Apnea Syndrome Common sleep disorder causes high blood pressure and heart attacks Message: Sleep apnea is very common. It is estimated that 158 million people worldwide suffer from sleep

More information

Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners. M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017

Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners. M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017 Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017 Case of S.R. S.R. is a 39 year old female referred for suspected obstructive

More information

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the

More information

Sleep Bruxism and Sleep-Disordered Breathing

Sleep Bruxism and Sleep-Disordered Breathing Sleep Bruxism and Sleep-Disordered Breathing Author STEVEN D BENDER, DDS*, Associate Editor EDWARD J. SWIFT JR., DMD, MS Sleep bruxism (SB) is a repetitive jaw muscle activity with clenching or grinding

More information

Outcomes of Upper Airway Surgery in Obstructive Sleep Apnea

Outcomes of Upper Airway Surgery in Obstructive Sleep Apnea Original Research Outcomes of Upper Airway Surgery in Obstructive Sleep Apnea Hadiseh Hosseiny 1, Nafiseh Naeimabadi 1, Arezu Najafi 1 *, Reihaneh Heidari 1, Khosro Sadeghniiat-Haghighi 1 1. Occupational

More information

Tolerance of Positive Airway Pressure following Site-Specific Surgery of Upper Airway

Tolerance of Positive Airway Pressure following Site-Specific Surgery of Upper Airway 34 The Open Sleep Journal, 2008, 1, 34-39 Open Access Tolerance of Positive Airway Pressure following Site-Specific Surgery of Upper Airway Ho-Sheng Lin *,#,1,2, Roger Toma #,2, Cara Glavin 2, Mark Toma

More information

in China Shanghai Office Beijing Office (+86) (+86)

in China Shanghai Office Beijing Office (+86) (+86) SLEEP Apnea in China Guide 2018-2019 Shanghai Office (+86) 21 2426 6400 Beijing Office (+86) 010 6464 0611 www.pacificprime.cn Follow us on WeChat t A comprehensive overview of sleep apnea Perhaps you

More information

Oral appliance therapy in obstructive sleep apnea: Long-term adherence and patients experiences

Oral appliance therapy in obstructive sleep apnea: Long-term adherence and patients experiences Journal section: Medically compromised patients in Dentistry Publication Types: Research doi:10.4317/medoral.22158 http://dx.doi.org/doi:10.4317/medoral.22158 : Long-term adherence and patients experiences

More information

Oral Appliances for the Treatment of Obstructive Sleep Apnea

Oral Appliances for the Treatment of Obstructive Sleep Apnea Sweta Gupta et al REVIEW ARTICLE 10.5005/jp-journals-10039-1110 Oral Appliances for the Treatment of Obstructive Sleep Apnea 1 Sweta Gupta, 2 Ravi Bhandari, 3 DK Agarwal, 4 Preeti Bhattacharya, 5 Ankur

More information

Adjustable Thermoplastic Mandibular Advancement Device for Obstructive Sleep Apnea: Outcomes and Practicability

Adjustable Thermoplastic Mandibular Advancement Device for Obstructive Sleep Apnea: Outcomes and Practicability The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Adjustable Thermoplastic Mandibular Advancement Device for Obstructive Sleep Apnea: Outcomes and Practicability

More information